Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis
Clicks: 190
ID: 269556
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
190 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyMint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In the present meta-analysis, levosimendan infusion in patients with ADHF appeared to reduce BNP regardless of the comparator (except for dopamine), and also improve LVEF and increase HR in after vs. before use comparisons but not compared to controls. Future larger studies on the benefit of levosim …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (47 words).
Try re-searching for a better abstract.
| Reference Key |
s2019herzeffect
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhou S;Zhang L;Li J;; |
| Journal | herz |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Prospective Studies
l zhang
pmid:29637229
doi:10.1007/s00059-018-4693-3
s zhou
j li
cardiotonic agents* / therapeutic use
heart failure* / drug therapy
hydrazones
pyridazines*
simendan* / therapeutic use
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.